McKesson Corporation MCK

866.64 (2.72) (0.31%) as of 25 Sep
Market cap
$101.8B
P/E
23.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

McKesson Corporation (MCK) EV/Sales

As of 25 September 2026, McKesson Corporation (MCK) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.1× (April 2020) to 0.3× (March 2015); the current reading is higher than 87% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2026 0.3× 11.72%
FY2025 0.3× (0.08%)
FY2024 0.3× 21.89%
FY2023 0.2× (1.93%)
FY2022 0.2× 25.98%
FY2021 0.2× 40.48%
FY2020 0.1× (7.75%)
FY2019 0.1× (20.78%)
FY2018 0.2× (15.20%)
FY2017 0.2× (7.92%)

Quarterly

Period EV/Sales Change
Jun 2026 0.2× (14.96%)
Mar 2026 0.3× 3.01%
Dec 2025 0.3× 2.00%
Sep 2025 0.3× (0.37%)
42 more quarters

Against its own ten years

Low 0.1× High 0.3×
Ten-year median 0.2×
Current reading's percentile 87

EV/Sales against peers

Company EV/Sales
YI 111, Inc. Sponsored ADR compare 0.0×
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.2×
MCK McKesson Corporation 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. compare 0.9×
AHG Akso Health Group Sponsored ADR compare 1.5×
FOCL FocalTherics compare 2.4×
Medical Distribution industry median 0.6×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MCK